Trials / Completed
CompletedNCT03660943
A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain
A Randomized, Double-blind, Placebo-controlled, 2-Injection, 52-Week Study to Evaluate the Efficacy and Safety of Intra-articular Injections of CNTX-4975-05 in Subjects With Chronic, Moderate-to-severe Osteoarthritis Knee Pain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 332 (actual)
- Sponsor
- Centrexion Therapeutics · Industry
- Sex
- All
- Age
- 40 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, placebo-controlled, 2-injection, 52-week study to evaluate the efficacy and safety of intra-articular injections of CNTX-4975-05 in subjects with chronic, moderate-to-severe osteoarthritis knee pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Receiving Placebo Injection |
| DRUG | CNTX-4975-05 | Receiving CNTX-4975-05 Injection |
Timeline
- Start date
- 2018-09-09
- Primary completion
- 2020-06-11
- Completion
- 2020-06-11
- First posted
- 2018-09-07
- Last updated
- 2022-07-21
- Results posted
- 2022-07-21
Locations
30 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03660943. Inclusion in this directory is not an endorsement.